229 related articles for article (PubMed ID: 31084333)
1. Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores.
Rivera-Caravaca JM; Marín F; Vilchez JA; Gálvez J; Esteve-Pastor MA; Vicente V; Lip GYH; Roldán V
Stroke; 2019 Jun; 50(6):1372-1379. PubMed ID: 31084333
[TBL] [Abstract][Full Text] [Related]
2. Enhancing the 'real world' prediction of cardiovascular events and major bleeding with the CHA
Roldán V; Rivera-Caravaca JM; Shantsila A; García-Fernández A; Esteve-Pastor MA; Vilchez JA; Romera M; Valdés M; Vicente V; Marín F; Lip GYH
Ann Med; 2018 Feb; 50(1):26-34. PubMed ID: 28892413
[TBL] [Abstract][Full Text] [Related]
3. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA
Rivera-Caravaca JM; Roldán V; Esteve-Pastor MA; Valdés M; Vicente V; Lip GYH; Marín F
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28729407
[TBL] [Abstract][Full Text] [Related]
6. Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation.
Sharma A; Hijazi Z; Andersson U; Al-Khatib SM; Lopes RD; Alexander JH; Held C; Hylek EM; Leonardi S; Hanna M; Ezekowitz JA; Siegbahn A; Granger CB; Wallentin L
Circulation; 2018 Oct; 138(16):1666-1676. PubMed ID: 29871978
[TBL] [Abstract][Full Text] [Related]
7. Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48.
Berg DD; Ruff CT; Jarolim P; Giugliano RP; Nordio F; Lanz HJ; Mercuri MF; Antman EM; Braunwald E; Morrow DA
Circulation; 2019 Feb; 139(6):760-771. PubMed ID: 30586727
[TBL] [Abstract][Full Text] [Related]
8. Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.
Roldán V; Marín F; Muiña B; Torregrosa JM; Hernández-Romero D; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2011 Jun; 57(25):2496-504. PubMed ID: 21497043
[TBL] [Abstract][Full Text] [Related]
9. Blood Biomarkers for the Early Diagnosis of Stroke: The Stroke-Chip Study.
Bustamante A; López-Cancio E; Pich S; Penalba A; Giralt D; García-Berrocoso T; Ferrer-Costa C; Gasull T; Hernández-Pérez M; Millan M; Rubiera M; Cardona P; Cano L; Quesada H; Terceño M; Silva Y; Castellanos M; Garces M; Reverté S; Ustrell X; Marés R; Baiges JJ; Serena J; Rubio F; Salas E; Dávalos A; Montaner J
Stroke; 2017 Sep; 48(9):2419-2425. PubMed ID: 28716979
[TBL] [Abstract][Full Text] [Related]
10. Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project.
Rivera-Caravaca JM; Roldán V; Romera M; Esteve-Pastor MA; Valdés M; Lip GYH; Vicente V; Marín F
J Gen Intern Med; 2018 Jun; 33(6):847-854. PubMed ID: 29569024
[TBL] [Abstract][Full Text] [Related]
11. Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA
Rivera-Caravaca JM; Roldán V; Esteve-Pastor MA; Valdés M; Vicente V; Marín F; Lip GYH
Am Heart J; 2018 Mar; 197():27-34. PubMed ID: 29447781
[TBL] [Abstract][Full Text] [Related]
12. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy.
Hijazi Z; Oldgren J; Andersson U; Connolly SJ; Ezekowitz MD; Hohnloser SH; Reilly PA; Vinereanu D; Siegbahn A; Yusuf S; Wallentin L
Circulation; 2012 Apr; 125(13):1605-16. PubMed ID: 22374183
[TBL] [Abstract][Full Text] [Related]
13. β-Trace protein and prognosis in patients with atrial fibrillation receiving anticoagulation treatment.
Vílchez JA; Roldán V; Manzano-Fernández S; Fernández H; Avilés-Plaza F; Martínez-Hernández P; Vicente V; Valdés M; Marín F; Lip GYH
Chest; 2013 Nov; 144(5):1564-1570. PubMed ID: 23975142
[TBL] [Abstract][Full Text] [Related]
14. Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time.
Hijazi Z; Lindahl B; Oldgren J; Andersson U; Lindbäck J; Granger CB; Alexander JH; Gersh BJ; Hanna M; Harjola VP; Hylek EM; Lopes RD; Siegbahn A; Wallentin L
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645934
[TBL] [Abstract][Full Text] [Related]
15. Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?
García-Fernández A; Roldán V; Rivera-Caravaca JM; Hernández-Romero D; Valdés M; Vicente V; Lip GY; Marín F
Sci Rep; 2017 Jan; 7():41565. PubMed ID: 28134282
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation.
Aulin J; Siegbahn A; Hijazi Z; Ezekowitz MD; Andersson U; Connolly SJ; Huber K; Reilly PA; Wallentin L; Oldgren J
Am Heart J; 2015 Dec; 170(6):1151-60. PubMed ID: 26678637
[TBL] [Abstract][Full Text] [Related]
17. Dynamic assessment of CHA
Serna MJ; Rivera-Caravaca JM; López-Gálvez R; Soler-Espejo E; Lip GYH; Marín F; Roldán V
Rev Esp Cardiol (Engl Ed); 2024 Mar; ():. PubMed ID: 38460882
[TBL] [Abstract][Full Text] [Related]
18. CHA2DS2-VASc score and blood biomarkers to identify patients with atrial high-rate episodes and paroxysmal atrial fibrillation.
Wakula P; Neumann B; Kienemund J; Thon-Gutschi E; Stojakovic T; Manninger M; Scherr D; Scharnagl H; Kapl M; Pieske B; Heinzel FR
Europace; 2017 Apr; 19(4):544-551. PubMed ID: 28431065
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial.
Apostolakis S; Lane DA; Buller H; Lip GY
Thromb Haemost; 2013 Nov; 110(5):1074-9. PubMed ID: 24048467
[TBL] [Abstract][Full Text] [Related]
20. NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and the Risk of Stroke.
Di Castelnuovo A; Veronesi G; Costanzo S; Zeller T; Schnabel RB; de Curtis A; Salomaa V; Borchini R; Ferrario M; Giampaoli S; Kee F; Söderberg S; Niiranen T; Kuulasmaa K; de Gaetano G; Donati MB; Blankenberg S; Iacoviello L;
Stroke; 2019 Mar; 50(3):610-617. PubMed ID: 30786848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
